Amphotericin B Revisited
Amphotericin B, one of the first systemic antifungal agents, has been in use since the past six decades. In light of the recent outbreak of mucormycosis (black fungus) cases during the second coronavirus disease 2019 wave in India, the relevance of knowing the chief aspects of this drug has been ren...
Main Authors: | Sahil Kumar, Vandana Roy |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
Series: | MAMC Journal of Medical Sciences |
Subjects: | |
Online Access: | http://www.mamcjms.in/article.asp?issn=2394-7438;year=2021;volume=7;issue=2;spage=104;epage=108;aulast=Kumar |
Similar Items
-
Isolated renal mucormycosis in children: A case report and review of the literature
by: Sachit Anand, et al.
Published: (2021-01-01) -
REFRACTORY FUNGAL VAGINITIS TREATED BY TOPICAL AMPHOTERICIN B. Review
by: Falah Hasan Obayes AL-Khikani
Published: (2020-06-01) -
In Vitro Activity of Amphotericin B in Combination with Statins against Clinical and Environmental Rhizopus oryzae Strains
by: Mahsa NAEIMI ESHKALETI, et al.
Published: (2019-05-01) -
The successful use of amphotericin B followed by oral posaconazole in a rare case of invasive fungal sinusitis caused by co-infection with mucormycosis and aspergillus
by: Sharana Mahomed, et al.
Published: (2015-01-01) -
Encochleated Amphotericin B: Is the Oral Availability of Amphotericin B Finally Reached?
by: Maria Aigner, et al.
Published: (2020-05-01)